Best Recovery Technology Protocols: mHBOT + Whole-Body Photobiomodulation + Whole-Body Extreme Cold

Article summary:

This article covers three modern recovery technologies and explains how to combine them into clear, practical protocols.

If you recognise any of the situations below, this article can save time and reduce guesswork:

• You struggle to recover even though you sleep and train “correctly”.
• You have pain, stiffness, or overload symptoms that return easily.
• You feel overstimulated, sleep restlessly, or have trouble calming down in the evening.
• You experience fatigue or brain fog and want a clear action plan.
• You have considered hyperbaric oxygen therapy, red light therapy, or cryotherapy, but you do not know what to choose or how to combine them.
• Or you have never heard of these recovery technologies, but you are willing to try new ways to support your wellbeing.

The recovery technologies covered in this article

• Mild/low-pressure hyperbaric oxygen therapy (mHBOT): You breathe oxygen in a mildly pressurised environment. This increases oxygen availability in tissues and supports the body’s repair processes.
• Whole-body red light therapy (PBM): The body is exposed to red and near-infrared light. This supports the cell’s “energy centres” (mitochondria) and may improve circulation in tissues.
• Whole-body cryotherapy (WBC): The body is exposed to very cold air for a short time. This affects the nervous system and may dampen pain signalling and reduce symptoms of overload.

Common reasons people use these methods:

• muscle soreness and overload symptoms
• poor sleep and overstimulation
• stress and inadequate recovery
• brain fog and fatigue
• recovery from training

In these situations, the problem is rarely just one thing. It is usually a combination: tissues are overloaded, the nervous system is overactive, and cellular energy production cannot keep up. That is why one method is not always enough.

What this article gives you

The article covers three key areas:

• It explains in simple terms what these therapies do in the body and why they may support recovery.
• It shows how to combine the therapies for different goals, such as better sleep, less pain, or recovery from high load.
• It provides practical protocols with clear durations and sequences, because sequence can change how the session feels and what it emphasises (alertness vs downshifting vs pain relief).

A key principle

These methods are not magic tricks. They are tools that work best when:

• the dose is appropriate
• the sequence is chosen correctly
• the goal is clear (sleep, pain, recovery, alertness)

The purpose of this article is to make the topic easy to understand and provide you with a practical framework for choosing a suitable protocol for your situation.

Note: This article discusses mHBOT, meaning low-pressure hyperbaric oxygen therapy designed for wellness use (typically 1.5 ATA), not medical HBOT.

I recommend reading the in-depth articles on each technology separately:

1. Hyperbaric Oxygen Therapy
2. Red Light Therapy
3. Cold Exposure and Cryotherapy

Disclaimer: This content is intended for general information only and does not replace medical advice, diagnosis, or treatment. The suitability of these methods should be evaluated individually with a qualified healthcare professional.

Introduction

Recovery is a biological process that requires energy, oxygen, and regulation. The body regulates these through three main systems:

• Mitochondrial energy production (ATP and redox)
• Microcirculation and tissue oxygen delivery
• Autonomic nervous system and inflammatory signaling

mHBOT, PBM, and cryotherapy target different points within the same system. These mechanisms form a clear continuum:

• Whole-body red light therapy (PBM) increases mitochondrial capacity and signaling.(1)
• mHBOT increases oxygen availability and activates repair pathways through oxygen fluctuation.(2)
• Whole-body cryotherapy alters autonomic responses and pain and inflammation pathways.(3)

For this reason, all three interventions can support the same goal from different directions, especially when combined and used regularly.

mHBOT: Definition and Key Differences from HBOT

mHBOT is low-pressure hyperbaric oxygen therapy. mHBOT typically uses pressures of around 1.2–1.5 ATA, and oxygen concentrations vary by device and implementation. This differs from medical HBOT, which typically uses higher pressures and 100% oxygen.(4)

The practical idea behind mHBOT is simple: increased pressure raises the partial pressures of inhaled gases and increases the dissolution of oxygen in plasma. This increases the tissue oxygen gradient and supports aerobic metabolism.(5)

The Most Important Biological Principle of mHBOT

Oxygen fluctuation drives the response

Many of the benefits of mHBOT can be explained by a model in which the cell responds to oxygen fluctuation, not merely to the absolute oxygen level. This phenomenon is called the hyperoxic-hypoxic paradox (HHP).(6)

In the HHP model, repeated hyperoxia activates pathways that hypoxia normally activates, such as:

• HIF
• VEGF
• Sirtuins

These pathways are linked to angiogenesis, tissue repair and cellular stress tolerance.

Stem cell mobilization with hyperbaric air

An important data point for mHBOT is the observation that even hyperbaric air can mobilize cellular and cytokine responses. The study by MacLaughlin and colleagues reported that hyperbaric air mobilizes stem/progenitor cells and alters cytokines.(7)

This supports the idea that lower pressures can be biologically relevant when the treatment is repeated as a series.

Whole-Body Photobiomodulation: The Biological Core

PBM refers to the use of red and near-infrared light to regulate biological functions. It is not based on heating tissue. It is based on a photochemical signal.(8)

The mitochondria are the primary target

Photobiomodulation (PBM) acts primarily on mitochondria because red and near-infrared light are effectively absorbed by cytochrome c oxidase (complex IV) in the mitochondrial electron transport chain. Light absorption can detach nitric oxide, which inhibits the enzyme, enhances electron transfer, increases mitochondrial membrane potential, and increases ATP formation, after which broader redox- and gene-level signaling is also initiated.(9)

Nitric oxide (NO) and microcirculation

Photobiomodulation (PBM) can increase the amount of biologically active nitric oxide (NO) in tissues. PBM can release NO and activate endothelial NO production, thereby improving endothelial function and increasing vasodilation. This change improves microcirculation and perfusion, allowing tissue to receive more oxygen and nutrients and to use oxygen more efficiently in aerobic metabolism.(10)

Clinical evidence for whole-body red light therapy (PBM)

Clinical studies on whole-body PBM have been published, reporting benefits related to pain and quality of life in fibromyalgia. Fitzmaurice and colleagues reported the feasibility and promising efficacy of whole-body PBM in fibromyalgia.(11)

Navarro-Ledesma and colleagues reported reductions in pain and improvements in quality of life in fibromyalgia with whole-body PBM in a randomized, blinded design.(12)

These studies do not yet prove all performance-related claims, but they support the model that whole-body red light therapy can elicit systemic responses.

Whole-Body Cryotherapy: The Biological Core

Cold exposure is a physiological stressor. It affects the nervous system, circulation, and pain pathways. Dose determines the response. My scientific review on cold exposure emphasizes four dose factors: temperature, time, surface area, and rate of cooling.

Autonomic response and alertness

Extreme cold (whole-body cryotherapy, WBC) acutely activates the sympathetic nervous system. WBC exposure raises blood norepinephrine concentration even after a single session, thereby increasing alertness and potentially heightening perceived arousal during and immediately after treatment. Research evidence shows that −110 °C WBC clearly increased norepinephrine after the first session, and that autonomic nervous system responses were measured concurrently, supporting the model of sympathetic activation and increased alertness.(13)

Inflammatory markers and extreme cold

A meta-analysis of randomized studies on exposure to extreme cold has been published, reporting increased IL-10 and decreased IL-1β. Whole-body extreme cold treatment, or cryotherapy (WBC), can alter inflammation biology, but the response depends on the method and dose.(14)

Combination Logic: Why These Three Fit the Same Protocol

In this model, each intervention does a different job.

1) mHBOT adds the “fuel”

mHBOT increases the amount of oxygen dissolved in plasma and increases oxygen diffusion into tissues.

2) Red light therapy increases the “engine capacity”

PBM increases mitochondrial electron transport chain activity and ATP production.

3) Whole-body cryotherapy makes the “regulation optimal”

WBC alters autonomic regulation and pain and inflammation pathways.

When these are combined, three synergistic effects emerge:

• mHBOT + PBM can increase aerobic energy because PBM improves mitochondrial utilization and mHBOT increases oxygen availability.
• WBC can reduce pain and alter inflammatory markers, which may support perceived recovery.
• The whole combination can function as a series of “three signals,” in which energy, oxygen, and the nervous system are directed toward the same recovery goal.

Evidence for Multimodal Combinations

The Healthspan Project: multi-modal wellness pilot

The Healthspan Project was a six-month retrospective pilot study in which healthy adults (n = 25) participated in a repeated weekly wellness program. The study is valuable because it examines “real-life” use, in which people do not perform only one intervention, but use several recovery methods in parallel.(15)

The study reported that the program included several therapies, the key ones in this article being whole-body cryotherapy (WBC), mild hyperbaric oxygen therapy (mHBOT) and whole-body red light therapy (PBM). In addition, the program included an infrared sauna, IV vitamin injections, and lifestyle coaching (exercise, nutrition, and alcohol use), which makes the overall setup a realistic model of how people typically build recovery routines.

The strength of the pilot study is that it reports changes in several measurable outcomes, not only experiences. The article describes changes in biomarkers and biometric measures over six months, supporting the idea that long-term, regular multimodal use may be associated with changes in health and recovery.

The Business Wire press release describes this “wellness therapies” package as a practical implementation and presents it as a stacking model in which several therapies are used in parallel and repeatedly.(16)

A limitation is that the study is retrospective and multimodal, so it was not designed to answer two “laboratory-level” questions:

• Which single intervention explains most of the changes
• Which sequence of interventions would be best

These do not reduce the value of the study. They only mean that The Healthspan Project serves as evidence of feasibility and the potential benefits of a long-term multimodal model, not as the “final” proof of a single method or as the solution to the optimal sequence.

Table: Summary of the intervention showing the treatment sessions received per participant

Therapy (abbreviation)	Mean (SD)	Unit/note
Whole-body extreme cold (WBC)	46.88 (44.97)	sessions
Infrared sauna (IR sauna)	17.69 (19.96)	sessions
Photobiomodulation / red light therapy (PBM)	40.31 (49.30)	sessions
Compression therapy	13.50 (16.80)	sessions
Mild hyperbaric oxygen therapy (mHbOT)	21.13 (18.92)	sessions
Intravenous micronutrients (IV*)	27.06 (16.47)	sessions
Intramuscular micronutrients (IM*)	15.63 (10.54)	sessions
Participants (n)	16	persons
Days in intervention	213.88 (115.32)	days

• This summary was calculated from participants for whom treatment sessions had been recorded (n = 16). All participants (n = 25) were included in the protocol and received treatments for 6 months.
• IV micronutrients included individualized combinations of: vitamin C (500 mg), B vitamins (thiamine HCl 100 mg, riboflavin 2 mg, niacinamide 100 mg, dexpanthenol 2 mg, pyridoxine HCl 2 mg), glutathione (400 mg).
• IM micronutrients included: vitamin D (100,000 IU), arginine (100 mg), ornithine (50 mg), lysine (50 mg), citrulline (50 mg), methionine–choline–inositol combination (2 mL), B12 (1000 mcg).

Protocols: mHBOT-Centered Framework

This section presents the protocols as model-based wholes. The purpose of the models is to describe a clear structure, sequence, and dose logic for different use cases. The protocols do not lock treatment to a specific device, but instead function as a framework that can later be adjusted according to the device, for example, in terms of power, dosing range, treatment time, temperature, and practical implementation.

Shared Dose Parameters (per session)

Mild hyperbaric oxygen therapy (mHBOT): 60–90 min, pressure 1.2–1.5 ATA (for recovery often 1.2–1.3 ATA)

• 60 min (light “reset”)
  • When the load is moderate, the goal is light recovery, or the user is new to mHBOT.
  • The shorter exposure provides a sufficient increase in dissolved O₂ and oxygen partial pressure while keeping the total dose moderate. This fits situations where the goal is a signal and relaxation without “too much” at once.
• 75 min (standard “Holy Trinity” session)
  • A typical recovery day: the stress load is clear, but a maximum dose is not needed.
  • In practice, 75 min is a good compromise because it provides sufficient exposure time for the tissue oxygen increase to stabilize while keeping the session easy to repeat within a series. Serial use is essential for the response.
• 90 min (intensive “repair block”)
  • When the load is high (travel, sleep deprivation, competition, high inflammatory symptom load), or when a stronger tissue dose is desired.
  • The longer duration increases “total exposure” (time × partial pressure), which may support a stronger regenerative response when used in series. It is not automatically better, but it is justified when the need for recovery is high, and the user tolerates the treatment well.

Whole-body red light therapy or photobiomodulation (PBM): typically 10–20 min (in studies 6–20 min)

• 6 min (priming, low dose)
  • When the user is sensitive to PBM, or the treatment is done immediately after mHBOT and a reliable, non-excessive dose is desired.
  • The smaller dose minimizes the risk that PBM exceeds the optimal dose window. This works when the goal is light mitochondrial and perfusion stimulation without “over-signaling.”
• 12 min (standard recovery dose)
  • The basic session for most users, aimed at mitochondrial activation and microcirculation support.
  • In practice, the middle range often falls within the dose window in which ATP and signaling responses are emphasized without inhibition. This is a safe default for whole-body treatment.
• 15 min (stronger “mitochondria + NO” block)
  • For an experienced user, a good response at a 12 min dose, or a clear need for tissue energy support.
  • Longer exposure increases the number of photons, which may strengthen mitochondrial and NO pathway activation if the device's output is moderate and the user does not overreact. If the response weakens, return to 12 or 6 minutes.

Whole-body cryotherapy (WBC): 2–3 min, around −110 to −160 °C (device-specific adjustment)

• 1 min (minimum, neural “snap”)
  • When: first-time user, stress-sensitive user, or the goal is only a small reduction in pain signaling without a large sympathetic spike.
  • A short dose activates cold receptors and gives a pain pathway effect with a lower total load. This is the best way to “test the response.”
• 2 min (standard, good response-risk ratio)
  • Most users, most recovery situations.
  • Two minutes is typically enough to produce a clear autonomic and perceived recovery response without the exposure becoming too stressful.
• 3 min (maximum, for experienced users)
  • Experienced WBC user and a clear need for managing pain/load symptoms.
  • Longer exposure increases the cold dose and may strengthen analgesia, but it also increases the load and the individual stress response. For this reason, 3 min is not the standard, but a choice when the response is predictable.

“The Holy Trinity of Recovery” Model

Sequence A: mHBOT → PBM → WBC

Goal: recovery, reduced inflammatory load, parasympathetic restoration.

• mHBOT gives tissues a higher oxygen supply.
• Whole-body red light therapy (PBM) activates mitochondria and increases microcirculation.
• Whole-body extreme cold reduces pain and can alter inflammatory markers.

When this works well:

• When the goal is “downshift” and perceived recovery
• When the load was high, but training adaptation is not the maximum priority

Risk logic:
Being too aggressive with cold immediately after hypertrophy training can weaken muscle adaptation.

Sequence B: WBC → PBM → mHBOT

Goal: alertness and stress tolerance signal first; repair afterward.

• WBC gives a strong autonomic signal.
• PBM can support energy production after the cold signal.
• mHBOT can support the HHP response and regenerative pathways in serial treatment.

When this works well:

• When the goal is “priming,” meaning increased activity and alertness
• When the person tolerates cold well
• When mHBOT is used as a treatment series and not as a “one-time trick.”

Sequence C: PBM → mHBOT → WBC

Goal: mitochondria first, oxygen second, inflammation and pain relief last.

• PBM activates mitochondrial and NO pathways.
• mHBOT increases oxygen supply and may support the HHP response.
• WBC provides analgesia and a possible anti-inflammatory shift.

Protocols by Use Case

Recovery technologies work best when selected according to the goal. The same combination is not best for all situations, because load, nervous system state, and training goal change, and the dose and sequence that produce the best response vary. The following protocols are divided by use case so that the appropriate whole can be found quickly and dosing can be built on a clear logic.

Recovery from heavy load (not hypertrophy-focused)

• mHBOT 60–90 min
• PBM 8–15 min whole-body
• WBC 2–3 min

Rationale: mHBOT increases tissue oxygen, PBM enhances mitochondrial function, and WBC reduces pain and can alter inflammatory markers.

Maximizing training adaptation (hypertrophy focus)

• PBM before training, 6–12 min, 30–90 min before training, or later on the same day, 10–15 min, 4–8 h after training
• mHBOT 60–75 min on a separate recovery day or ≥ 6 h after training (evening)
  
• WBC only later, 1–2 min, ≥ 6–8 h after training, or the next day, 2 min (standard) or 3 min (for experienced users)

Rationale: Too-early cold exposure can suppress inflammatory signals that muscle adaptation uses.

Reducing stress load and balancing the nervous system

• mHBOT 60–75 min at lower pressure (1.3 ATA, 1.5 ATA is also okay, with shorter treatment time) and calm breathing in connection with a recovery day
• PBM 6–12 min in the evening or 10–15 min in connection with recovery
• WBC only as a short and controlled exposure of 1–2 min, preferably in the morning or daytime (the exposure is stopped clearly before a “compelling cold stress experience”).
  • Frequency: 1–2x/week at first; later, can be increased to 2–3x/week if the response is clearly positive.

Rationale: mHBOT can support a recovery environment without a strong stress spike. PBM can support systemic calming depending on the dose. WBC can, at an appropriate dose, activate parasympathetic tone and increase heart rate variability.(17)

Two-Modality Protocols

Shared basic parameters (per session)

These are “article-level” default ranges that can be adjusted by device:

• mHBOT: 60–90 min, 1.2–1.5 ATA
• Whole-body PBM: 10–20 min (the dose-response is biphasic, so the middle range often works best)
• WBC: 2–3 min (a short dose produces an autonomic and pain-pathway response without a long thermal load)

Protocol 1A: mHBOT → PBM

Goal: tissue oxygenation + mitochondrial energy production, for a recovery day.

Duration:

• mHBOT 60–90 min
• PBM 10–20 min

Why and how:
mHBOT increases dissolved oxygen in plasma and increases the oxygen gradient in tissues. This supports aerobic metabolism and repair processes.
PBM activates mitochondrial function (ATP production, redox signaling) and may increase NO bioavailability, thereby supporting endothelial function and perfusion. This can improve oxygen utilization in tissue.

When this works well:

• When the load was high, and the goal is “steady regeneration” without cold stress
• When the user reacts to cold with a strong stress response

Protocol 1B: PBM → mHBOT

Goal: “priming” through perfusion and mitochondrial activation, followed by mHBOT.**

Duration:

• PBM 10–20 min
• mHBOT 60–90 min

Why and how:

• PBM can increase NO-mediated perfusion and support endothelial function.
• mHBOT increases tissue oxygen and supports oxygen fluctuation-related repair pathways in serial use.

When this works well:

• When PBM is experienced as calming and the user wants to do it before a long oxygen session
• When the goal is a “parasympathetic” recovery package

Combination 1C: Serial treatment (2–4 weeks)

Goal: cumulative response, not a “one-time trick.”

Structure:

• week 1–2: 3–5×/week mHBOT + 2–4×/week PBM
• week 3–4: 2–3×/week mHBOT + 2–3×/week PBM

Duration per session: mHBOT 60–90 min, PBM 10–20 min.

Protocol 2A: mHBOT → WBC

Goal: tissue oxygenation and regeneration, then analgesia and perceived recovery.

Duration:

• mHBOT 60–90 min
• WBC 2–3 min

Why and how:

• mHBOT supports tissue oxygenation, and repeated exposure functions as a signal for repair pathways.
• WBC affects autonomic regulation and pain signaling and may reduce inflammatory markers.

When this works well:

• When the main problem is muscle soreness/load symptoms and next-day functional capacity
• When cold is wanted as the “ending” rather than as a way to increase alertness

Protocol 2B: WBC → mHBOT

Goal: rapid autonomic activation, then calm repair.

Duration:

• WBC 2–3 min
• mHBOT 60–90 min

Why and how:

• WBC provides a brief, sympathetic signal that may increase alertness and modulate pain pathways.
• mHBOT provides a prolonged tissue oxygenation phase and supports repair pathways with serial use.

When this works well:

• When the user wants increased alertness and does mHBOT afterward as a “recovery block”
• When cold is well tolerated

Combination 2C: Load period (7–10 days)

Goal: symptom management and recovery support during a demanding period.

Structure:

• WBC 3–5×/7–10 days (2–3 min)
• mHBOT 2–4×/7–10 days (60–90 min)

Protocol 3A: PBM → WBC

Goal: energy production and perfusion, then pain and load symptoms.

Duration:

• PBM 10–20 min
• WBC 1–2 min

Why and how:

• PBM supports mitochondrial energy production and NO-mediated perfusion.
• WBC provides a short autonomic and pain-regulation stimulus.

When this works well:

• When the user wants the “steady” response of PBM and uses cold only as a short ending
• When the goal is perceived recovery and not maximal training adaptation on the same day

Protocol 3B: WBC → PBM

Goal: alertness first, then support for energy and perfusion.

Duration:

• WBC 2–3 min
• PBM 10–20 min

Why and how:

• WBC increases autonomic nervous system activation.
• PBM can support mitochondria and perfusion after the cold signal.

When this works well:

• When the user experiences cold as invigorating and PBM as “balancing.”
• When this is done earlier in the day and not right before sleep, if cold increases alertness

Combination 3C: Minimum session (daily routine)

Goal: low threshold and repeatability.

Structure:

• PBM 10–12 min 4–6×/week
• WBC 2–3 min 1–3×/week

Why: The response to PBM is often built through repetition, and WBC is kept less frequent so that total stress does not rise too much.

Selection Guide: Which Pair to Choose for What

Subtle regeneration and energy:

• Choose: mHBOT + PBM
• Why: oxygen + mitochondria + perfusion without cold stress.

Pain, DOMS (delayed onset muscle soreness), and load symptoms:

• Choose: PBM + WBC or mHBOT + WBC
• Why: WBC provides a rapid pain-pathway effect; PBM or mHBOT provides the background energy and repair phase.

Alertness and “priming”:

• Choose: WBC → PBM or WBC → mHBOT
• Why: WBC gives an autonomic signal; PBM/mHBOT builds recovery afterward.

Safety and Limitations

mHBOT requires evaluation of contraindications and controlled increases and decreases in pressure, because pressure load and inhaled oxygen can cause adverse effects in high-risk groups and when the treatment is implemented incorrectly. PBM requires dose control because it follows dose-response logic: too small a dose remains ineffective and too large a dose can weaken the biological response.

Whole-body cryotherapy can acutely increase blood pressure and respiratory load and cause a strong autonomic response, so exposure is kept controlled and the dose is selected according to the goal and the individual’s tolerance (scientific references on safety and limitations can be found in their own articles – see the beginning of this article).

Current Research Evidence and Testable Hypotheses

1) Direct studies on the combination of the three interventions (mHBOT + PBM + extreme cold)

There are still a few studies in the scientific literature that use the same study design to specifically test the combination of mHBOT, whole-body PBM, and whole-body extreme cold, while simultaneously comparing different sequences (A/B/C). This is a key gap, because sequence may alter autonomic load, perfusion, and mitochondrial response even in the short term.

From a practical perspective, the closest “real-life” equivalent is The Healthspan Project, which is a six-month retrospective, multi-method pilot in healthy adults and in which the program included at least extreme cold (WBC), mHBOT, infrared sauna, and whole-body PBM, as well as lifestyle coaching and vitamin injections. The study reported biomarker and biometric changes during long-term use (see earlier).(15)

2) What closest comparable literature already exists (and what protocols are used in it)

Although there are few “exactly similar” multi-modality programs, the literature contains three practically important close relatives, each of which provides protocol-level relevant information:

Multimodal recovery studies in sport (short duration, highly controlled)

The study by Hausswirth and colleagues compares WBC, far-infrared heat (FIR), and passive recovery after exercise, measuring recovery over 48 hours. This is important because it shows that several “recovery tech” methods can be tested in the same setup and that the effects can be distinguished in a short time window.

Protocol-level lesson for this article: short, clearly standardized sessions (for example, 2–3 day “blocks” and 24–48 h follow-up) are a realistic way to test sequences A/B/C.(18)

Combinations of environmental stressors (cold + hypoxia/hyperoxia ± heat) – mechanistic literature

A recent review compiles studies examining the separate and combined effects of cold, heat, contrast therapy, and hypoxia on recovery after muscle damage. This literature is close to “stacking” thinking, although it is not identical to wellness clinic protocols.(19)

In addition, there are animal and physiological studies in which intermittent cold exposure and intermittent hypobaric hypoxia are tested separately and together in connection with muscle regeneration.(20–21)

Research on combined stressors supports the idea that “dose and timing” determine the response and that combinations may have additive or sequence-dependent effects.

Long-term multimodal wellness programs with biomarkers (long duration, weaker causal separation)

The Healthspan Project represents this category. It is not a sequence comparison or a pure RCT, but it is very useful because it demonstrates the feasibility of long-term multimodal use and identifies measures that should also be used in future sequence studies (biomarkers, body composition, fitness).(15)

3) Sequence hypothesis (mHBOT–PBM synergy)

Hypothesis: mHBOT + PBM produce the greatest mitochondrial benefit when PBM is done temporally close to mHBOT (before or after), because PBM activates mitochondria through light-mediated signaling and mHBOT increases oxygen availability for aerobic energy production. This is a biologically coherent conclusion based on PBM’s mitochondrial mechanisms and mHBOT’s tissue oxygenation and oxygen fluctuation-related repair pathways.

Testable protocol (example for a study design):

• PBM → mHBOT vs mHBOT → PBM vs control
• Measures: HRV, perceived recovery, DOMS, performance test, selected inflammation and stress markers.

4) “Triple hormetic signal” hypothesis

Hypothesis: light, oxygen, and cold form three hormetic signals that guide the same recovery process from three directions:

• PBM directs mitochondria and perfusion
• mHBOT directs tissue oxygenation and repair pathways through oxygen fluctuation
• WBC directs autonomic regulation and pain/inflammation pathways

In this model, the key testable factor is the sequence of interventions, as it may alter whether the response emphasizes alertness, downregulation, pain modulation, or tissue repair signals. This is in line with the importance of oxygen partial pressure and tissue oxygen fluctuation and connects to PBM’s mitochondrial logic and the autonomic response to cold exposure.

5) Practical research path: how these protocols should be validated

Based on the literature, the most reasonable progression is three-phase:

• Short, controlled sequence tests (24–48 h) in a sports model, such as a WBC vs FIR (infrared sauna)-type setup with PBM and mHBOT.
• Medium-length blocks (2–6 weeks), in which HRV, sleep, perceived recovery, and training response are measured.
• A long program (3–6 months) with a Healthspan-type biomarker panel, but this time with predefined sequence groups.

Summary

This article integrates three recovery technologies into a single model and protocol framework: mHBOT, whole-body red light therapy (photobiomodulation, PBM), and whole-body extreme cold (WBC). The whole rests on three key biological variables: tissue oxygen availability, mitochondrial energy production and signaling, and regulation of the autonomic nervous system and pain/inflammation pathways.

mHBOT increases the partial pressure of oxygen and its dissolution in plasma, thereby supporting tissue oxygenation and aerobic metabolism, especially with serial treatments.
PBM primarily targets mitochondria, supports electron transport chain function, and may increase NO bioavailability and perfusion; its effects depend on dose, as PBM follows dose-response logic. WBC produces a short, strong autonomic stimulus, dampens pain signaling, and can, in some settings, alter inflammatory markers; dose determines the benefit and the risk.

The central idea of the article is that sequence affects the response's emphasis: the same content may emphasize alertness, downregulation, pain modulation, or tissue repair signals depending on whether the oxygen, light, or cold stimulus is applied first. This way of thinking fits with the “oxygen fluctuation” model and links to PBM’s mitochondrial logic and cold’s autonomic response. Evidence for multimodal programs remains limited, but the Healthspan Project serves as an important example of long-term multimodal use and associated measurable changes, even though it does not resolve the sequence optimization problem.

Finally, the article presents testable hypotheses and practical protocols: mHBOT–PBM synergy should be studied in terms of temporal proximity, and the “triple hormetic signal” model should be tested using sequence comparisons that measure HRV, perceived recovery, performance, and selected biomarkers.

Scientific references:

1. Hamblin, M. R. (2018). Mechanisms and mitochondrial redox signaling in photobiomodulation. Photochemistry and photobiology, 94(2), 199-212.
2. Cannellotto, M., Yasells García, A., & Landa, M. S. (2024). Hyperoxia: effective mechanism of hyperbaric treatment at mild-pressure. International journal of molecular sciences, 25(2), 777.
3. Solaro, N., Giovanelli, L., Bianchi, L., Piterà, P., Verme, F., Malacarne, M., ... & Lucini, D. (2024). Whole-body cold stimulation improves cardiac autonomic control independently of the employed temperature. Journal of Clinical Medicine, 13(24), 7728.
4. Ortega, M. A., Fraile-Martinez, O., García-Montero, C., Callejón-Peláez, E., Sáez, M. A., Álvarez-Mon, M. A., ... & Canals, M. L. (2021). A general overview on the hyperbaric oxygen therapy: applications, mechanisms and translational opportunities. Medicina, 57(9), 864.
5. Hisamoto, K., Okubo, N., Fujita, M., Fukushima, H., Okizuka, Y., Yamanaka, T., ... & Takahashi, K. (2025). Mild hyperbaric hyperoxia improves aerobic capacity and suppresses cardiopulmonary stress during the maximal cycle-ergometer test. Plos one, 20(5), e0323885.
6. Hadanny, A., & Efrati, S. (2020). The hyperoxic-hypoxic paradox. Biomolecules, 10(6), 958.
7. MacLaughlin, K. J., Barton, G. P., Braun, R. K., MacLaughlin, J. E., Lamers, J. J., Marcou, M. D., & Eldridge, M. W. (2023). Hyperbaric air mobilizes stem cells in humans; a new perspective on the hormetic dose curve. Frontiers in neurology, 14, 1192793.
8. Anders, J. J., Lanzafame, R. J., & Arany, P. R. (2015). Low-level light/laser therapy versus photobiomodulation therapy. Photomedicine and laser surgery, 33(4), 183-184.
9. De Freitas, L. F., & Hamblin, M. R. (2016). Proposed mechanisms of photobiomodulation or low-level light therapy. IEEE Journal of selected topics in quantum electronics, 22(3), 348-364.
10. Kashiwagi, S., Morita, A., Yokomizo, S., Ogawa, E., Komai, E., Huang, P. L., ... & Atochin, D. N. (2023). Photobiomodulation and nitric oxide signaling. Nitric Oxide, 130, 58-68.
11. Fitzmaurice, B. C., Heneghan, N. R., Rayen, A. T., Grenfell, R. L., & Soundy, A. A. (2023). Whole-body photobiomodulation therapy for fibromyalgia: a feasibility trial. Behavioral Sciences, 13(9), 717.
12. Navarro-Ledesma, S., Carroll, J., Burton, P., & Ana, G. M. (2023). Short-term effects of whole-body photobiomodulation on pain, quality of life and psychological factors in a population suffering from fibromyalgia: a triple-blinded randomised clinical trial. Pain and Therapy, 12(1), 225-239.
13. Louis, J., Theurot, D., Filliard, J. R., Volondat, M., Dugué, B., & Dupuy, O. (2020). The use of whole-body cryotherapy: time-and dose-response investigation on circulating blood catecholamines and heart rate variability. European Journal of Applied Physiology, 120(8), 1733-1743.
14. He, J., Zhang, X., Ge, Z., Shi, J., Guo, S., & Chen, J. (2025). Whole-body cryotherapy can reduce the inflammatory response in humans: a meta-analysis based on 11 randomized controlled trials. Scientific Reports, 15(1), 7759.
15. Chun, E., Crete, A., Neal, C., Joseph, R., & Pojednic, R. (2024, March). The healthspan project: a retrospective pilot of biomarkers and biometric outcomes after a 6-month multi-modal wellness intervention. In Healthcare (Vol. 12, No. 6, p. 676). MDPI.
16. https://www.businesswire.com/news/home/20240502032238/en/6-Month-Study-Shows-Improved-Body-Composition-Biomarkers-For-Healthy-Adults-Consistently-Using-Wellness-Therapies?utm_source=chatgpt.com 
17. Louis, J., Theurot, D., Filliard, J. R., Volondat, M., Dugué, B., & Dupuy, O. (2020). The use of whole-body cryotherapy: time-and dose-response investigation on circulating blood catecholamines and heart rate variability. European Journal of Applied Physiology, 120(8), 1733-1743.
18. Hausswirth, C., Louis, J., Bieuzen, F., Pournot, H., Fournier, J., Filliard, J. R., & Brisswalter, J. (2011). Effects of whole-body cryotherapy vs. far-infrared vs. passive modalities on recovery from exercise-induced muscle damage in highly-trained runners. PloS one, 6(12), e27749.
19. Rousse, Y., Sautillet, B., Costalat, G., Brocherie, F., & Millet, G. P. (2025). Isolated and Combined Effects of Cold, Heat and Hypoxia Therapies on Muscle Recovery Following Exercise-Induced Muscle Damage: Y. Rousse et al. Sports Medicine, 55(11), 2721-2751.
20. Santocildes, G., Viscor, G., Pagès, T., & Torrella, J. R. (2024). Simulated altitude is medicine: intermittent exposure to hypobaric hypoxia and cold accelerates injured skeletal muscle recovery. The Journal of Physiology, 602(21), 5855-5878.
21. Sánchez-Nuño, S., Santocildes, G., Rebull, J., Bardallo, R. G., Girabent-Farrés, M., Viscor, G., ... & Torrella, J. R. (2024). Effects of intermittent exposure to hypobaric hypoxia and cold on skeletal muscle regeneration: Mitochondrial dynamics, protein oxidation and turnover. Free Radical Biology and Medicine, 225, 286-295.